121 related articles for article (PubMed ID: 3051406)
1. Monoclonal antibodies in the treatment of hematopoietic malignancies.
Houghton A; Scheinberg D
Semin Hematol; 1988 Jul; 25(3 Suppl 3):23-9. PubMed ID: 3051406
[TBL] [Abstract][Full Text] [Related]
2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
3. Role of antibody therapy in lymphoid malignancies.
Dearden CE
Br Med Bull; 2007; 83():275-90. PubMed ID: 17942451
[TBL] [Abstract][Full Text] [Related]
4. Cell surface antigen and molecular targeting in the treatment of hematologic malignancies.
Countouriotis A; Moore TB; Sakamoto KM
Stem Cells; 2002; 20(3):215-29. PubMed ID: 12004080
[TBL] [Abstract][Full Text] [Related]
5. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
6. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
[TBL] [Abstract][Full Text] [Related]
7. Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule.
Ceriani RL; Blank EW
Cancer Res; 1988 Aug; 48(16):4664-72. PubMed ID: 3396015
[TBL] [Abstract][Full Text] [Related]
8. Progress review: intrathecal and intratumoral injection of radiolabelled monoclonal antibodies (MoAbs) for the treatment of central nervous system (CNS) malignancies.
Hopkins K; Kemshead JT
J Drug Target; 1993; 1(3):175-83. PubMed ID: 8069558
[TBL] [Abstract][Full Text] [Related]
9. Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects.
Gökbuget N; Hoelzer D
Ann Hematol; 2004 Apr; 83(4):201-5. PubMed ID: 14648023
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody therapy of lymphoid malignancy.
Lowder JN; Meeker TC; Levy R
Cancer Surv; 1985; 4(2):359-75. PubMed ID: 3842318
[TBL] [Abstract][Full Text] [Related]
11. Clinical status of monoclonal antibodies in the treatment of colorectal carcinoma.
Mellstedt H; Frodin JE; Masucci G
Oncology (Williston Park); 1989 Dec; 3(12):25-32; discussion 37-9, 42. PubMed ID: 2701408
[TBL] [Abstract][Full Text] [Related]
12. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
13. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
15. Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components.
Ceriani RL; Blank EW; Peterson JA
Cancer Res; 1987 Jan; 47(2):532-40. PubMed ID: 3791239
[TBL] [Abstract][Full Text] [Related]
16. Antibody-targeted therapy for low-grade lymphoma.
Vose JM
Semin Hematol; 1999 Oct; 36(4 Suppl 6):15-20. PubMed ID: 10530712
[TBL] [Abstract][Full Text] [Related]
17. Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
Horton HM; Bernett MJ; Pong E; Peipp M; Karki S; Chu SY; Richards JO; Vostiar I; Joyce PF; Repp R; Desjarlais JR; Zhukovsky EA
Cancer Res; 2008 Oct; 68(19):8049-57. PubMed ID: 18829563
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody technology.
Tami JA; Parr MD; Brown SA; Thompson JS
Am J Hosp Pharm; 1986 Nov; 43(11):2816-25. PubMed ID: 3541584
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies in hematological malignancies: past, present and future.
Tazi I; Nafil H; Mahmal L
J Cancer Res Ther; 2011; 7(4):399-407. PubMed ID: 22269399
[TBL] [Abstract][Full Text] [Related]
20. Newer monoclonal antibodies for hematological malignancies.
Castillo J; Winer E; Quesenberry P
Exp Hematol; 2008 Jul; 36(7):755-68. PubMed ID: 18565392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
